SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy is actively discussing a potential rebound for the project, with community members coordinating to build momentum and promote buying activity. Despite the speculative nature of these claims, participants are highlighting technical charts and historical performance as reasons for optimism, even as others warn of significant volatility.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is experiencing significant volatility and renewed retail interest, driven by speculation surrounding upcoming supply-reducing burn mechanisms and potential legal developments. Community sentiment remains polarized, with many long-term holders expressing optimism about a potential price resurgence while skeptics continue to warn of historical risks and the speculative nature of the current momentum.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending amid community anticipation for the upcoming Vegas conference and ongoing discussions surrounding potential regulatory progress with the Clarity Act. While many holders are positioning for long-term utility in the financial sector, sentiment remains polarized as others express frustration over recent price consolidation and the persistent influence of broader market volatility.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is trending as investors monitor institutional accumulation, particularly following reports of major treasury purchases by companies like BitMine and continued integration into traditional finance settlements. Market sentiment remains split between excitement over potential policy milestones like the Clarity Act and skepticism driven by recent price consolidation, with community discussions heavily focused on the balance between long-term institutional adoption and short-term volatility.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is gaining attention following the announced preliminary design for the Phase 3 trial of CAD-1005, which aims to treat heparin-induced thrombocytopenia. While some community members are optimistic about the clinical pathway and upcoming milestones, others are expressing skepticism regarding promotional activity and potential future financing requirements.

Got that dog in you? - Fueled by a mantra of tokenized self-belief, doginme is representative of the community's collective efforts to embrace and embolden that dog in them. doginme stands for knowing yourself and having that unshakable drive to keep pushing forward. doginme was originally launched in February 2024 when the Farcaster founder was asked if he owned a dog, to which he replied affirmatively: "no but I got that dog in me"

doginme

Doginme is generating significant community conversation as investors debate its potential for a breakout, driven by its status as a low-market-cap meme token on the Base chain. Enthusiasts are actively rallying around the 'dog in me' branding and shared cultural narrative, while others remain cautious, debating the token's long-term sustainability.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as community members aggressively debate whether the token is primed for a significant breakout or a potential collapse. While some holders are actively calling for increased buying to trigger a 'god candle' and remove zeros from the price, others are warning of a pump-and-dump scheme and encouraging a rotation into newer meme coins.

Roundhill ETF Trust - Roundhill Memory ETF

Investors are fueling intense bullish sentiment toward the memory sector, viewing DRAM, NAND, and HBM as the essential infrastructure supporting a multi-year AI super-cycle. The community is actively debating the sustainability of this demand, with many favoring direct exposure via ETFs like $DRAM to capture gains from the industry's concentrated oligopoly and structural supply-demand imbalances.

Bank of America Corp. is a bank and financial holding company, which engages in the provision of banking and nonbank financial services. It operates through the following segments: Consumer Banking, Global Wealth and Investment Management (GWIM), Global Banking, Global Markets, and All Other. The Consumer Banking segment offers credit, banking, and investment products and services to consumers and small businesses. The GWIM segment focuses on solutions to meet clients’ needs through a full set of investment management, brokerage, banking, and retirement products. The Global Banking segment deals with lending-related products and services, integrated working capital management and treasury solutions to clients, and underwriting and advisory services. The Global Markets segment includes sales and trading services, as well as research, to institutional clients across fixed-income, credit, currency, commodity, and equity businesses. The All Other segment consists of asset and liability management activities, equity investments, non-core mortgage loans and servicing activities, the net impact of periodic revisions to the mortgage servicing rights valuation model for both core and non-core MSRs, other liquidating businesses, residual expense allocations and other. The company was founded by Amadeo Peter Giannini in 1904 and is headquartered in Charlotte, NC.

Bank Of America Corp.

Bank of America Corp

Bank of America is trending as investors weigh strong Q1 earnings results, driven by robust trading and investment banking revenue, against rising macro uncertainty and credit quality concerns. While some in the community highlight positive analyst outlooks and dividend stability, others are actively debating the bank's exposure to private credit and questioning the long-term impact of its digital loyalty initiatives.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as investors monitor a critical patent infringement case currently before the Supreme Court, with the community actively debating whether the potential for a favorable ruling or an eventual acquisition creates an asymmetric risk-reward opportunity. Market participants are closely analyzing recent financial stabilization and strategic restructuring efforts as indicators of the company's long-term valuation potential while navigating persistent generic competition.

statis crypto Watchlist

Bitcoin

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Best Biotech Stocks To Keep An Eye On - May 2nd

Danaher, Moderna, and Vertex Pharmaceuticals are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that research, develop, manufacture, or commercialize biologically based products and technologiessuch as drugs, vaccines...

Stocks Keep Record Highs on Renewed US-Iran Hopes  The Close 5/1/2026

Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are TIAA Wealth Management's...

Moderna (NASDAQ:MRNA) Announces Earnings Results

Moderna (NASDAQ:MRNA - Get Free Report) issued its quarterly earnings results on Friday. The company reported ($3.40) EPS for the quarter, topping analysts' consensus estimates of ($4.44) by $1.04. Moderna had a negative return on equity of 30.15% and a negative net margin of 145.16%.The firm had...

Moderna (MRNA) Q1 2026 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Biotech Stocks To Follow Today - May 1st

Moderna, Danaher, Lakewood-Amedex Biotherapeutics, Celcuity, and Vertex Pharmaceuticals are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that use biological research and technologies to discover, develop, and commercia...

Moderna Reports Q1 Loss, Stock Jumps on Strong International Sales

MRNA narrows Q1 loss and beats revenue estimates as international vaccine sales surge, lifting shares despite hefty litigation charges.

Moderna Q1 Earnings Call Highlights

Moderna (NASDAQ:MRNA) reported first-quarter 2026 revenue of $400 million, topping the company's guidance and rising $300 million from the prior-year period, as management pointed to deliveries under...

Moderna Reports Q1 2026 Results: Full Earnings Call Transcript

Moderna's revenue more than tripled in Q1, driven by international COVID vaccine sales

The company posted $389 million in first-quarter revenue, well above analyst expectations, with 80% coming from international markets...

Futures Rise, Oil Slides On Iran Ceasefire Optimism After Best Month For Stocks Since 2020

Futures Rise, Oil Slides On Iran Ceasefire Optimism After Best Month For Stocks Since 2020 US equity futures are higher, set for a new all time high, as the rally that's pushed Wall Street to record...

$MRNA Q1 &#39;26 Earnings Results &amp; Recap

Moderna reiterates its plan to deliver up to 10% revenue growth and GAAP operating expense reductions in 2026, excluding a non-recurring litigation settlement charge. Moderna projects year-end cash and investments of $4.5 to $5.0 billion for 2026.

Stocktwits

Moderna Inc

 Q1 '26 Earnings Results & Recap

Moderna reiterates its plan to deliver up to 10% revenue growth and GAAP operating expense reductions in 2026, excluding a non-recurring litigation settlement charge. Moderna projects year-end cash and investments of $4.5 to $5.0 billion for 2026.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

MRNA
Moderna Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MRNA News

MRNAModerna Inc